NCT00847418已完成1 期
Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine
University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家开始时间: 2009年2月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is the determination of blood concentration and the effectiveness of esketamine after nasal application.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •age ≥18 years ≤ 45 years
- •non-smoking
- •BMI 18-27
排除标准
- •abuse of drugs
- •known or supposed hypersensitivity and/or contraindication against ketamine or additives
- •participation of another clinical study within the last 30 days
- •chronic obstructed nose breathing or nasal polyps
- •dug allergy
- •blood donation within the last two months
研究组 & 干预措施
Esketamine
Experimental
干预措施: esketamine hydrochloride (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
终止
1 期
Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart DiseaseDexmedetomidineCongenital Heart DiseaseNCT03417999Children's Hospital of Philadelphia28
已完成
1 期
Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver FunctionAsthmaNCT00419237GlaxoSmithKline20
招募中
不适用
Bioequivalence Study of Somatropin in Healthy Human Volunteers..IRCT20130626013776N20AryaTinaGene Biopharmaceutical Co30
已完成
不适用
Bioequivalence Study of Pegfilgrastim in Healthy Human VolunteersIRCT20130626013776N8AryaTinaGene Biopharmaceutical Co24
已完成
1 期
Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary HyperhidrosisPrimary Axillary HyperhidrosisNCT03037788Dr. August Wolff GmbH & Co. KG Arzneimittel30